Navigation Links
Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
Date:7/8/2008

t's tumor profile."

About the HERmark Breast Cancer Assay

HERmark is a proprietary diagnostic that accurately quantifies HER2 total protein levels and HER2 homodimerization in patients with breast cancer. HERmark is a CLIA-validated assay that is performed exclusively in Monogram's CAP-certified clinical reference laboratory in South San Francisco. Robust, accurate, sensitive and reproducible measurements of HER2 status are reported to physicians with a turnaround time of 7 days.

With the accurate measurements provided by HERmark, it is expected that as many as 15-20% of patients determined by conventional technologies to be HER2- negative would be reclassified by HERmark.

Key advantages of the HERmark Breast Cancer Assay include:

-- HERmark is highly sensitive and can detect HER2 at levels from 2,500 to over 1 million receptors per cell -- 7 to 10 times more sensitive than IHC.

-- HERmark provides a better measure of HER2 status by measuring the drug target -- the HER2 protein and HER2 homodimers -- rather than the HER2 gene.

-- The HERmark report is simple to interpret and provides a specific quantitative measure of HER2 expression, a HER2 status of "positive", "negative" or "equivocal" and indicates, relative to conventional measurements, how positive or how negative the patient is.

-- Clinical studies demonstrate that HERmark is an accurate method for stratifying patients with metastatic breast cancer who are more likely to respond to Herceptin-containing therapy.

Assay measurements: Physicians ordering HERmark receive a report indicating a specific quantitative measurement of the levels of HER2 total protein and HER2 homodimer, together with a comparison of where the patient's level of HER2 total protein falls within ranges of HERmark measurements that have been previously correlated in over 1,000 patients with HER2-positive and HER2-negative status by central laboratory FISH and IHC assessments. Th
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
2. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
3. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
4. Monogram Announces First Medicare Payment for Trofile(TM)
5. The Center for Professional Innovation and Education (CfPIE) Announces the First True Certification Program for Document Management Professionals in the Life Sciences
6. The Center for Professional Innovation and Education (CfPIE) Announces a New Global Regulatory Certification Track
7. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
8. NHP Announces Second Quarter Earnings Release Date and Conference Call/Webcast
9. Ventas Announces 2008 Second Quarter Earnings Release Date and Conference Call
10. QuikByte Software, Inc. Announces Changes to Board of Directors and Executive Ranks
11. March of Dimes Announces Nursing Scholarship Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... September 03, 2014 Recently, Top ... hosting companies and announced that JustHost ( http://www.justhost.com/track/seohosts ... the webmasters. , “The hosting suppliers we recommend ... their competitors on hosting features, uptime and server ... 10 Best SEO Hosting says. “We believe that ...
(Date:9/2/2014)... 02, 2014 The use of Xarelto ... is growing at a rapid pace, even as ... courts around the U.S., Bernstein Liebhard LLP reports. According ... Medicine, within a year of its 2011 launch, patients ... warfarin, a blood thinner that has been in use ...
(Date:9/2/2014)... breast cancer in California, the percentage undergoing a double ... procedure was not associated with a lower risk of ... study in the September 3 issue of JAMA ... removal of one breast was associated with a higher ... the study. , Randomized trials have demonstrated similar survival ...
(Date:9/2/2014)... The Dream2Walk Foundation along with Gas Monkey Bar and Grill ... Cord Injury Awareness Month featuring full band performances by Zane ... Automotive will be there hosting a Hot Rod, Rat Rod, ... The car show is Pre 1964 only, with a $50.00 ... There will be trophies for top 3 and best of ...
(Date:9/2/2014)... supplements did not reduce delirium in seniors who had ... Many older hospital patients experience the sudden, severe confusion ... sleep-wake cycle. A lack of the hormone melatonin may ... has been little research into whether melatonin supplements would ... average age 84, who had hip fracture surgery. About ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 3Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 4Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:Gas Monkey Hosts Concert in Dallas Benefiting Dream2Walk Foundation with Linear Automotive 2
... HEIGHTS, N.J., May 2 Authentidate,Holding Corp. (Nasdaq: ... workflow,management software and web-based services, today announced the ... on Friday, May 2,2008, at the Grand Hyatt ... election of the following individuals to,serve on Authentidate,s ...
... Inc.,(Nasdaq: OSTE ) announces today that on April ... response to its notification to Nasdaq that,Robert W. Gunn, ... of,Directors, Audit and Compensation Committees, passed away unexpectedly on,April ... independent directors,serving on its Audit Committee and is not ...
... ATLANTA, May 2 Now in its 11th year ... cancer research, Georgia Power,s Run for,the Reason relay team ... and support the American Cancer Society. This year,s relay ... Georgia Power president and,CEO who passed away from cancer ...
... On the eve of the British Columbia inquiry into the ... CMAJ (Canadian Medical Association Journal) finds that in some cases, ... evidence is contrary to current views that stun guns only ... the pulses generated by stun guns are designed to incapacitate ...
... Properties, Inc.,s (NYSE: NHP ) Board of Directors declared ... that will be paid on,June 6, 2008 to shareholders of ... of Directors declared cash dividends of,$1.9375 per share on its ... be paid on June 30, 2008 to stockholders of,record on ...
... 2 Hill-Rom Holdings,Inc., (NYSE: HRC ) invites ... president and chief executive officer, Hill-Rom. He will be,speaking ... Las Vegas on,Thursday, May 15, 2008 at 9:10 a.m. ... listen to the live presentation via the internet,link at ...
Cached Medicine News:Health News:Authentidate Holding Corp. Announces Results From Annual Meeting of Stockholders 2Health News:Authentidate Holding Corp. Announces Results From Annual Meeting of Stockholders 3Health News:Osteotech Announces the Unexpected Passing of Audit Committee Member Leads to Receipt of Nasdaq Deficiency Letter 2Health News:Relay Team Runs to Raise Funds for the American Cancer Society 2Health News:Evidence that stun guns may stimulate the heart 2Health News:NHP Declares Its Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 2Health News:NHP Declares Its Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 3
(Date:9/2/2014)... Calif. , Sept. 2, 2014 Depomed, ... it intends to offer, subject to market and other ... Notes due 2021 (the "Notes"). Depomed, Inc. ("Depomed") expects ... option to purchase up to an additional $34.5 million ... Co. LLC and RBC Capital Markets, LLC will act ...
(Date:9/2/2014)...  XBiotech announced today interim results from its ... US for its anti-cancer agent Xilonix™. ... being evaluated in advanced colorectal cancer patients where ... endpoint of the study is overall survival, comparing ... population provided only palliative therapy for cachexia. ...
(Date:9/2/2014)... September 2, 2014 According ... Market Research "Latin America Home Healthcare Market (By ... Healthcare Devices, Mobility Assist Devices and Medical Supplies; ... Infusion Therapy and Unskilled Home Healthcare Services) - ... 2014 - 2020" the Latin American Home Healthcare ...
Breaking Medicine Technology:Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 2Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 3XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6
... , , SALT LAKE CITY , ... Heart Corporation ("WorldHeart" or "Company"), a developer of mechanical circulatory ...  the Company  received a NASDAQ Staff Deficiency Letter indicating that ... This Rule requires the Company to have at least three ...
... , BOSTON , Feb 5 ... to announce the Company has signed an agreement with Expert ... Company,s ISO 13485 quality management system (QMS) initiative. Expert Resource ... Endoscopy to create a quality management system that meets the ...
Cached Medicine Technology:NASDAQ Stock Market Confirms WorldHeart's Compliance With NASDAQ Listing Rule 5605 2Solos Endoscopy, Inc. Retains Expert Resource to Meet Requirements for ISO 13485 Quality Management System Initiative 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: